445 related articles for article (PubMed ID: 34753715)
1. Advances in systemic therapy for non-small cell lung cancer.
Miller M; Hanna N
BMJ; 2021 Nov; 375():n2363. PubMed ID: 34753715
[TBL] [Abstract][Full Text] [Related]
2. Unmet Clinical Need in the Management of Locally Advanced Unresectable Lung Cancer: Treatment Strategies to Improve Patient Outcomes.
Rajappa S; Sharma S; Prasad K
Adv Ther; 2019 Mar; 36(3):563-578. PubMed ID: 30693419
[TBL] [Abstract][Full Text] [Related]
3. Locally Advanced, Unresectable Non-Small Cell Lung Cancer.
Puri S; Saltos A; Perez B; Le X; Gray JE
Curr Oncol Rep; 2020 Mar; 22(4):31. PubMed ID: 32140986
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives.
Antoni D; Mornex F
Curr Opin Oncol; 2016 Mar; 28(2):104-9. PubMed ID: 26848885
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced non-small cell lung cancer: what is the optimal concurrent chemoradiation regimen?
Videtic GM
Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS32-7. PubMed ID: 22614963
[TBL] [Abstract][Full Text] [Related]
6. The evolving locally-advanced non-small cell lung cancer landscape: Building on past evidence and experience.
Méry B; Guy JB; Swalduz A; Vallard A; Guibert C; Almokhles H; Ben Mrad M; Rivoirard R; Falk AT; Fournel P; Magné N
Crit Rev Oncol Hematol; 2015 Nov; 96(2):319-27. PubMed ID: 26095618
[TBL] [Abstract][Full Text] [Related]
7. Superiority of concomitant chemoradiation over sequential chemoradiation in inoperable, locally advanced non-small cell lung cancer: challenges in the selection of appropriate chemotherapy.
Bi N; Wang L
Semin Radiat Oncol; 2015 Apr; 25(2):122-32. PubMed ID: 25771417
[TBL] [Abstract][Full Text] [Related]
8. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
Sweeney CJ; Sandler AB
Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
[TBL] [Abstract][Full Text] [Related]
10. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer.
Blackstock AW; Govindan R
J Clin Oncol; 2007 Sep; 25(26):4146-52. PubMed ID: 17827465
[TBL] [Abstract][Full Text] [Related]
11. Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.
Bayman NA; Blackhall F; Jain P; Lee L; Thatcher N; Faivre-Finn C
Clin Lung Cancer; 2008 Mar; 9(2):92-101. PubMed ID: 18501095
[TBL] [Abstract][Full Text] [Related]
12. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
13. Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review.
Baldini E; Tibaldi C; Delli Paoli C
Clin Transl Oncol; 2020 Oct; 22(10):1681-1686. PubMed ID: 32128671
[TBL] [Abstract][Full Text] [Related]
14. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Locally Advanced Non-Small Cell Lung Cancer.
Tam K; Daly M; Kelly K
Hematol Oncol Clin North Am; 2017 Feb; 31(1):45-57. PubMed ID: 27912833
[TBL] [Abstract][Full Text] [Related]
16. Treatment of lung cancer.
Gadgeel SM; Ramalingam SS; Kalemkerian GP
Radiol Clin North Am; 2012 Sep; 50(5):961-74. PubMed ID: 22974781
[TBL] [Abstract][Full Text] [Related]
17. Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer.
Huber RM; Reck M; Thomas M
Eur Respir J; 2013 Oct; 42(4):1119-33. PubMed ID: 23429914
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Lung Cancer-Improving Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer With Immunotherapy.
Sun L; Aggarwal C
Cancer J; 2020; 26(6):548-554. PubMed ID: 33298727
[TBL] [Abstract][Full Text] [Related]
19. Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.
Thatcher N; Heighway J
Oncologist; 2010; 15(10):1034-42. PubMed ID: 20930098
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
